Online inquiry

IVTScrip™ mRNA-Human ARNTL2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK26864MR)

This product GTTS-WK26864MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ARNTL2 protein. This product can be used in FOXN4+ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001248002.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 56938
UniProt ID Q8WYA1
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ARNTL2, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK26864MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK25512MR IVTScrip™ mRNA-Human APLP2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA APLP2
GTTS-WK15028MR IVTScrip™ mRNA-Human AHSP, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA AHSP
GTTS-WK26187MR IVTScrip™ mRNA-Human ARHGAP21, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA ARHGAP21
GTTS-WK9725MR IVTScrip™ mRNA-Human ACIN1, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ACIN1
GTTS-WK17963MR IVTScrip™ mRNA-Human ANXA5, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANXA5
GTTS-WK25693MR IVTScrip™ mRNA-Human ASB1, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ASB1
GTTS-WK27391MR IVTScrip™ mRNA-Human ARHGAP26, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP26
GTTS-WK26511MR IVTScrip™ mRNA-Human ARHGEF18, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARHGEF18
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →